Synthesis of Enantiomerically Pure Cyclopentene Building Blocks

Abstract

An efficient synthesis of the enantiomerically pure cis-annulated cyclopentenes 2 and ent-2 was established by the use of an enzymatic transesterification and hydrolysis, respectively, followed by an S_N2-type substitution with a benzyloxymethyl cuprate and a sigmatropic rearrangement. The advantage of this approach is the short sequence combined with an excellent overall yield and an enantiomeric excess of 99%.

cyclopentenes - enzymes - benzyloxymethyl cuprate - spinosyns - Claisen-Ireland rearrangement

References and Notes

1a Hodgson DM. Gibbs AR. Drew MGB. J. Chem. Soc., Perkin Trans. 1  1999,  3579 

1b Hodgson DM. Gibbs AR. Synlett  1997,  657 

1c Brown B. Hegedus LS. J. Org. Chem.  2000,  65:  1865 

2 Tietze LF. Brasche G. Stadler C. Grube A. Böhnke N. Angew. Chem. Int. Ed.  2006,  45:  5015 ; Angew. Chem. 2006, 118, 5137

3a Johnson CR. Esker JL. Van Zandt MC. J. Org. Chem.  1994,  59:  5854 

3b Zanoni G. Re S. Meriggi A. Castronovo F. Vidari G. Tetrahedron: Asymmetry  2001,  12:  1785 

3c Zanoni G. Porta A. Brunoldi E. Vidari G. J. Org. Chem.  2006,  71:  8459 

4 Crandall JK. Banks DB. Coyler RA. Watkins RJ. Watkins JP. J. Org. Chem.  1968,  33:  423 

5 Deardorff DR. Myles DC. MacFerrin KD. Tetrahedron Lett.  1985,  26:  5615 

6 Theil F. Schick H. Winter G. Reck G. Tetrahedron  1991,  47:  7569 

7

For the preparation of 7 the following modified procedure was used. A mixture of diol 4 (8.0 g, 80 mmol), Et₃N (7.7 mL, 56 mmol), vinyl acetate (11 mL, 0.12 mol) and pancreatin (30 g) in THF (150 mL) was stirred at r.t. until complete consumption of 4 (TLC). The mixture was filtered, the filter pad of the residue washed with EtOAc (3 × 50 mL) and the solvent evaporated under reduced pressure. Purification of the residue by column chromatography (n-pentane-EtOAc, 3:1) afforded acetate 7 as white crystals (8.2 g, 58 mmol, 72%, 99% ee). The diacetate 5 was isolated as by-product in 22% yield; [α]_D ²⁰ -69.0 (c 1.00, CHCl₃); R _f = 0.4 (n-pentane-EtOAc, 1:1). IR (KBr): 3387, 2922, 1726, 1359, 1253, 1087, 1020, 968, 910, 880, 841, 794, 606 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.66 (dt, J = 14.7, 3.8 Hz, 1 H, H_B-2), 2.06 (s, 3 H, H-2′), 2.85 (dt, J = 14.7, 7.3 Hz, 1 H, H_A-2), 4.70-4.75 (m, 1 H, H-3), 5.47-5.53 (m, 1 H, H-1), 5.97-6.01 (m, 1 H, H-4), 6.10-6.14 (m, 1 H, H-5). ¹³C NMR (50 MHz, CDCl₃): δ = 21.16 (COCH₃), 40.46 (C-2), 74.80 (C-1), 77.03 (C-3), 132.60 (C-4), 138.47 (C-5), 170.76 (OCOCH₃). MS (EI): m/z (%) = 142.1 (1) [M⁺], 99 (7) [C₅H₇O₂ ⁺], 82 (100) [C₅H₆O⁺], 43 (78) [C₂H₃O⁺].

8a Johnson CR. Bis SJ. Tetrahedron Lett.  1992,  33:  7287 

8b Reetz MT. Eipper A. Tielmann P. Mynott R. Adv. Synth. Catal.  2002,  9:  1008 

9

Synthesis of ent -7.
Novo sp 435 lipase (2.0 g) was added to a suspension of diacetate 5 (15.0 g, 81.5 mmol) in a buffer (pH 8, 400 mL) and the mixture was stirred for 18 h at r.t. After that, the reaction was filtered and washed with H₂O (100 mL) and EtOAc (2 × 200 mL). The aqueous layer was extracted with EtOAc (3 × 200 mL) and the combined organic fractions were dried (Na₂SO₄), filtered and concentrated under reduced pressure to afford monoacetate ent-7 as white crystals (11.1 g, 78.1 mmol, 96%, 99% ee); [α]_D ²⁰ +66 (c 1.00, CHCl₃). IR (film): 3387, 2922, 1726, 1359, 1253, 1087, 1062, 1020, 968, 910, 880, 841, 794, 606 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 1.66 (dt, J = 14.7, 3.8 Hz, 1 H, 2-H_B), 2.06 (s, 3 H, 2′-H), 2.85 (quint, J = 7.3 Hz, 1 H, 2-H_A), 4.70-4.75 (m, 1 H, 3-H), 5.47-5.53 (m, 1 H, 1-H), 5.97-6.01 (m, 1 H, 4-H), 6.10-6.14 (m, 1 H, 5-H). ¹³C NMR (50 MHz, CDCl₃): δ = 21.16, 40.46, 74.80, 77.03, 132.60, 138.47, 170.76. MS (EI, 70 eV): m/z (%) = 142.1 (1) [M⁺], 99 (7) [C₅H₇O₂ ⁺], 82 (100) [C₅H₆O⁺], 43 (78) [C₂H₃O⁺].

10

Synthesis of 8.
Magnesia turnings (575 mg, 23.6 mmol) were dried in vacuo at r.t. for 12 h. After activation with bromine and HgCl₂ a solution of benzyl chloromethyl ether (0.5 mL, 0.55 g, 3.5 mmol) in THF (2 mL) was added, whereupon the reaction started. The reaction mixture was then cooled immediately to -5 °C and more benzyl chloromethyl ether (1.5 mL, 1.65 g, 10.5 mmol) was added carefully as a solution in THF (20 mL). After additional stirring for 2.5 h at -5 °C the mixture was transferred into a suspension of CuCN (35 mg, 10 mol%) in THF (20 mL) at -20 °C and stirred for 5 min. Monoacetate 7 (550 mg, 3.90 mmol) was added and the reaction stirred for further 15 min. After addition of sat. NH₄Cl (20 mL) and aq NH₃ (20 mL) the aqueous layer was separated and extracted with EtOAc (3 × 70 mL). The combined organic layers were dried (Na₂SO₄) and the solvent removed under reduced pressure. Purification of the residue by column chromatography (n-pentane-EtOAc, 3:1) afforded benzyl ether 8 as a clear liquid (732 mg, 3.59 mmol, 92%); [α]_D ²⁰ +146.3 (c 1.00, CHCl₃); R _f = 0.17 (n-pentane-EtOAc, 3:1). IR (KBr): 3380, 3060, 2856, 1651, 1496, 1453, 1361, 1074, 1028, 738, 698 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.75 (s, 1 H, OH), 1.81-2.01 (m, 2 H, H₂-5), 3.12-3.24 (m, 1 H, H-4), 3.29-3.41 (m, 2 H, CH₂OBn), 4.51 (s, 2 H, CH₂Ph), 4.84-4.91 (m, 1 H, H-1), 5.89 (dt, J = 5.6, 2.2 Hz, 1 H, H-2), 5.97-6.01 (m, 1 H, H-3), 7.24-7.38 (m, 5 H, PhH). ¹³C NMR (75 MHz, CDCl₃): δ = 37.3, 44.8, 73.0, 73.9, 76.9, 127.5, 128.3, 134.3, 136.8, 138.3. MS (EI, 70 eV): m/z = 204.1 [M⁺]. HRMS (EI): m/z [M]⁺ calcd for C₁₃H₁₆O₂: 204.2649; found: 204.2649.

11

Synthesis of 9.
DIAD (3.94 g, 19.5 mmol) was added dropwise to a stirred solution of benzyl ether 8 (1.98 g, 9.74 mmol), Ph₃P (5.12 g, 19.5 mmol) and AcOH (2.23 mL, 2.34 g, 39.0 mmol) in Et₂O (60 mL) at 0 °C. After stirring for 30 min at 0 °C the reaction was filtered and the filtrate was washed with cold pentane (4 × 100 mL). The combined extracts were washed with sat. NaHCO₃ (100 mL) and the aqueous layer was separated and extracted with pentane (2 × 100 mL). The combined extracts were dried (Na₂SO₄) and evaporated under reduced pressure. Purification of the residue by column chromatography (PE-EtOAc, 20:1) gave acetate 9 as a colorless oil (4.56 g, 18.5 mmol, 95%); [α]_D ²⁰ -1.10 (c 1.00, CHCl₃); R _f = 0.24 (n-pentane-EtOAc, 15:1). UV/Vis (MeOH): λ_max (lg ε) = 204.5 (3.926), 251.0 (2.324), 257.0 (2.304), 263.0 (2.140) nm. IR (film): 3391, 3064, 2857, 1732, 1496, 1454, 1364, 1243, 1202, 1092, 1025, 907, 740, 708 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.54 (dt, J = 14.3, 4.1 Hz, 1 H, H_A-5), 1.99 (s, 3 H, CH₃), 2.46 (dt, J = 14.3, 7.9 Hz, 1 H, H_B-5), 2.92 (m_c, 1 H, H-4), 3.33-3.46 (m, 2 H, CH₂OBn), 4.52 (s, 2 H, CH₂Ph), 5.59-5.66 (m, 1 H, H-1), 5.84 (dt, J = 5.7, 2.3 Hz, 1 H, H-2), 6.03-6.07 (m, 1 H, H-3), 7.25-7.37 (m, 5 H, PhH). ¹³C NMR (50 MHz, CDCl₃): δ = 21.26, 33.59, 44.79, 73.08, 74.05, 79.47, 127.55, 127.57, 128.33, 130.49, 138.13, 138.30, 170.85. MS (EI, 70 eV): m/z (%) = 246.2 (1) [M⁺], 203.1 (4) [M - C₂H₃O⁺], 186.1 (12) [M - C₂H₄O₂ ⁺], 91 (100) [C₇H₇ ⁺]. HRMS (ESI): m/z [M + Na]⁺ calcd for C₈H₁₀NaO₂: 269.11482; found: 269.11473.

12

Synthesis of 10.
n-BuLi (2.5 M in hexane, 12.0 mL, 29.9 mmol) was added dropwise to a stirred solution of DIPA (4.33 mL, 3.10 g, 31.0 mmol) in THF (20 mL) at 0 °C. After 5 min HMPA (5 mL) was added and the reaction was cooled to -78 °C and stirred for further 10 min whereupon a solution of acetate 9 (5.08 g, 20.7 mmol) in THF (35 mL) was added dropwise. The reaction was maintained at -78 °C for additional 20 min. A solution of TBSCl (4.07 g, 27.0 mmol) in THF (5 mL) was added and the reaction was stirred at -78 °C for 5 min before warming to r.t. Then pentane (150 mL) and aq NaOH (0.1 M, 150 mL) were added. The aqueous layer was separated and extracted with pentane (2 × 150 ml). The combined pentane extracts were washed with aq NaOH (0.1 M, 2 × 100 mL), H₂O (100 mL), dried (Na₂SO₄) and the solvent evaporated to give the title compound as a yellow oil (7.45 g, 20.7 mmol, quant.) which was used without further purification steps for the next reaction; [α]_D ²⁰ +18.5 (c 1.00, CHCl₃). UV/Vis (MeOH): λ_max (lg ε) = 251.5 (2.728), 257.5 (2.734), 263.0 (2.666) nm. IR (film): 3426, 3063, 2929, 2855, 1734, 1496, 1454, 1363, 1244, 1093, 1026, 937, 873, 835, 770, 737, 698 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 0.24 [s, 6 H, Si(CH₃)₂], 0.89 [s, 9 H, (SiC(CH₃)₃], 1.57-1.60 (m, 1 H, H_A-5), 2.40-2.52 (m, 1 H, H_B-5), 2.80-2.96 (m, 1 H, H-4), 3.25-3.60 (m, 4 H, CH₂OBn, H₂-2′) 4.51 (s, 2 H, CH₂Ph), 5.59-5.65 (m, 1 H, H-1), 5.80-6.08 (m, 2 H, H-2, H-3). ¹³C NMR (75 MHz, CDCl₃): δ = -3.62, 17.94, 25.60, 33.57, 44.78, 69.40 73.08, 74.04, 79.49, 127.56, 128.33, 130.48, 138.13, 138.27, 160.51. MS (DCI): m/z (%) = 378.4 (12) [M + NH₄ ⁺], 361.4 (4) [M + H⁺], 264.2 (100) [C₁₅H₁₈O₃ + NH₄ ⁺].

13

Synthesis of 11.
A solution of crude silyl ketene acetal 10 (7.45 g, 20.7 mmol) in dry xylene (50 mL) was heated in a sealed tube to 180 °C for 18 h. After cooling to ambient temperature the solvent was removed under reduced pressure and the residue dissolved in THF (60 mL). Then, aq NaOH (2 M, 60 mL) was added and the reaction stirred vigorously for 2 h. Pentane was then added (100 mL) and the mixture extracted with aq NaOH (2 M, 3 × 150 mL). The combined aqueous layers were acidified to pH 1 with HCl (6 M) and extracted with EtOAc (3 × 200 mL). The combined organic layers were dried over Na₂SO₄ and the solvent evaporated under reduced pressure. Purification of the residue by column chromatography (pentane-EtOAc, 6:1 + 0.5% AcOH) gave acid 11 as a pale yellow oil (4.43 g, 18.0 mmol, 87%); [α]_D ²⁰ +76.1 (c 1.00, CHCl₃); R _f = 0.34 (n-pentane-EtOAc, 5:1, 6% AcOH). UV/Vis (MeOH): λ_max (lg ε) = 251.5 (2.265), 257.5 (2.321), 263.5 (2.201) nm. IR (film): 3060, 2926, 1706, 1496, 1453, 1410, 1364, 1276, 1200, 1098, 1028, 935, 735, 698 cm^-1. ¹H NMR (200 MHz, CDCl₃): δ = 2.04-2.14 (m, 1 H, H_B-4′), 2.21 (dd, J = 15.6, 9.0 Hz, 1 H, H_B-2), 2.32-2.46 (m, 1 H, H_A-4′), 2.58 (dd, J = 15.6, 6.5 Hz, 1 H, H_A-2), 2.70 (m_c, 1 H, H-5′), 3.13-3.24 (m, 1 H, H-1′), 3.42-3.52 (m, 2 H, CH₂OBn), 4.49 (s, 2 H, CH₂Ph), 5.72-5.75 (m, 2 H, H-2′, H-3′), 7.24-7.38 (m, 5 H, Ph-H). ¹³C NMR (50 MHz, CDCl₃): δ = 34.60, 34.89, 40.01, 42.32, 70.58, 73.01, 127.55, 127.65, 128.33, 130.38, 133.71, 138.10, 179.39. MS (EI, 70 eV): m/z (%) = 246.2 (4) [M⁺], 91 (100) [C₇H₇ ⁺]. HRMS (ESI): m/z [M + Na]⁺ calcd for C₁₅H₁₈NaO₃: 269.11482; found: 269.11487.

14

Synthesis of 2.
BCl₃ (ca. 1 M in CH₂Cl₂, 2.0 mL, 2.0 mmol) was added dropwise to a solution of acid 11 (246 mg, 1.00 mmol) in CH₂Cl₂ (10 mL) at -40 °C. The reaction was allowed to warm to 0 °C while being continuously stirred for 2 h. After being stirred for a further 15 min at 0 °C sat. NH₄Cl (5 mL) was added, the aqueous layer was separated and extracted with CH₂Cl₂ (3 × 50 mL). The combined organic extracts were dried (Na₂SO₄), filtered and evaporated under reduced pressure. After purification of the residue by column chromatography (n-pentane-Et₂O, 1:1) 2 was obtained as a white solid (124 mg, 890 µmol, 89%); [α]_D ²⁰ +51.0 (c 0.30, CH₂Cl₂); R _f = 0.22 (n-pentane-Et₂O, 1:1). IR (KBr): 3444, 3052, 2994, 2900, 2854, 1742, 1484, 1435, 1386, 1358, 1340, 1280, 1232, 1078, 991, 950, 861, 758, 724 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 2.21-2.31 (m, 1 H, H_B-7), 2.25 (dd, J = 15.0, 7.2 Hz, 1 H, H_B-4), 2.62-2.86 (m, 2 H, 7-H_A, H-7a), 2.66 (dd, J = 15.0, 6.4 Hz, 1 H, H_A-4), 3.26-3.40 (m, 1 H, H-4a), 4.10 (dd, J = 11.3, 6.4 Hz, 1 H, H_A-1) 4.30 (dd, J = 11.3, 4.3 Hz, 1 H, H_B-1), 5.56 and 5.76 (2 × m_c, 2 × 1 H, H-5, H-6). ¹³C NMR (75 MHz, CDCl₃): δ = 33.79, 33.87, 41.84, 70.27, 130.88, 131.79, 173.37. MS (EI, 70 eV): m/z = 138 (6) [M⁺], 66.0(100) [C₆H₆]⁺. HRMS (EI): m/z [M]⁺ calcd for C₈H₁₀O₂: 138.0681; found: 138.0681.